Systematic Evaluation of Antiviral Medication in Schizophrenia
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether antiviral medication will help improve
psychotic symptoms and cognition in individuals early in the course of schizophrenia or
schizoaffective disorder who are exposed to herpes simplex virus, type 1 (HSV 1), a virus
that causes commonly occurring and recurrent cold sores.
Phase:
Phase 2
Details
Lead Sponsor:
Konasale Prasad University of Pittsburgh
Collaborators:
Stanley Medical Research Institute Wayne State University